Article info

Download PDFPDF

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC
Free
  1. Correspondence to Professor Dr Kenneth O'Byrne, Hope Directorate, St James's Hospital, PO Box 580, James's Street, Dublin 8, Ireland; kobyrne{at}stjames.ie
View Full Text

Citation

Gately K, O'Flaherty J, Cappuzzo F, et al
The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC

Publication history

  • Accepted August 3, 2011
  • First published October 29, 2011.
Online issue publication 
December 13, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.